Changes in incidence and risk factors of Mycobacterium avium complex infections in patients with AIDS in the era of new antiretroviral therapies

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 20, Issue 7, 2001, Pages 498-501

  Tumbarello, M ^a   Tacconelli, E ^a   De Gaetano Donati, K ^a   Bertagnolio, S ^a   Longo, B ^a   Ardito, F ^a   Fadda, G ^a   Cauda, R ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INCIDENCE; INFECTION RISK; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM INTRACELLULARE AVIUM; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; VIREMIA;

EID: 0035725263     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00011292     Document Type: Article

References (15)

1. Mycobacterium avium complex and other atypical mycobacterial infections
2. Mycobacterium avium complex (MAC)
3. The international epidemiology of disseminated Mycobacterium avium complex infection in AIDS: International MAC study group
4. Incidence of Mycobacterium avium-intracellular complex bacteremia in human immunodeficiency virus-positive patients
5. The epidemiology of disseminated nontuberculosis mycobacterial infection in the acquired immunodeficiency syndrome (AIDS)
6. Changing incidence of AIDS-defining illness in the era of antiretroviral combination therapy
7. Effect of HAART on natural history of AIDS-related opportunistic disorders
8. Altered natural history of AIDS-related opportunistic infections in the era of potent combination antiretroviral therapy
9. Recurrence of Mycobacterium avium infection in patients receiving highly active antiretroviral therapy and antimycobacterial agents
10. Does in vitro susceptibility to rifabutin and ethambutol predict the response to treatment of Mycobacterium avium complex bacteremia with rifabutin, ethambutol, and clarithromycin?
11. Mycobacterium avium strains resistant to clarithromycin and azithromycin
12. Susceptibility testing for mycobacteria
13. Treatment of Mycobacterium avium complex infection: Do the results of in vitro susceptibility tests predict therapeutic outcome in humans?